A new study from the Research Institute of the McGill University Health Centre (RI-MUHC) confirms the benefits of fluvoxamine in preventing the risk of hospitalization following a COVID-19 infection.
Admin overload: Dr. Alykhan Abdulla argues we need scribes, we need more allied healthcare workers and we need more IT solutions in the second of a three-part series.
Being a pharmacist gives me the opportunity to make a meaningful difference in patients’ lives and to work alongside healthcare leaders and partners to continually improve the way we deliver patient care.